{"doi":"10.1136/bmjopen-2022-068623","title":"Couple-based lifestyle intervention to prevent type 2 diabetes: protocol for a randomised pilot trial","abstract":"INTRODUCTION: Type 2 diabetes is prevalent among US adults. Lifestyle interventions that modify health behaviours prevent or delay progression to diabetes among individuals at high risk. Despite the well-documented influence of individuals' social context on their health, evidence-based type 2 diabetes prevention interventions do not systematically incorporate participants' romantic partners. Involving partners of individuals at high risk for type 2 diabetes in primary prevention may improve engagement and outcomes of programmes. The randomised pilot trial protocol described in this manuscript will evaluate a couple-based lifestyle intervention to prevent type 2 diabetes. The objective of the trial is to describe the feasibility of the couple-based intervention and the study protocol to guide planning of a definitive randomised clinical trial (RCT). METHODS AND ANALYSIS: We used community-based participatory research principles to adapt an individual diabetes prevention curriculum for delivery to couples. This parallel two-arm pilot study will include 12 romantic couples in which at least one partner (ie, 'target individual') is at risk for type 2 diabetes. Couples will be randomised to either the 2021 version of the CDC's PreventT2 curriculum designed for delivery to individuals (six couples), or PreventT2 Together, the adapted couple-based curriculum (six couples). Participants and interventionists will be unblinded, but research nurses collecting data will be blinded to treatment allocation. Feasibility of the couple-based intervention and the study protocol will be assessed using both quantitative and qualitative measures. ETHICS AND DISSEMINATION: This study has been approved by the University of Utah IRB (#143079). Findings will be shared with researchers through publications and presentations. We will collaborate with community partners to determine the optimal strategy for communicating findings to community members. Results will inform a subsequent definitive RCT. TRIAL REGISTRATION NUMBER: NCT05695170.","journal":"BMJ Open","year":2023,"id":360233,"datarank":0.48203141097664,"base_score":2.302585092994046,"endowment":2.302585092994046,"self_citation_contribution":0.3453877639491069,"citation_network_contribution":0.13664364702753307,"self_endowment_contribution":0.3453877639491069,"citer_contribution":0.13664364702753307,"corpus_percentile":null,"corpus_rank":null,"citation_count":9,"citer_count":5,"citers_with_citation_signal":4,"citers_with_endowment":4,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9554,"is_data_producer":true,"deposit_databanks":{"ClinicalTrials.gov":["NCT05695170"]},"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1112100,"name":"Monique C Aguirre","orcid":null,"position":1,"is_corresponding":false},{"id":929727,"name":"Manuel Gutierrez Chavez","orcid":"0000-0003-3178-7662","position":2,"is_corresponding":false},{"id":1111660,"name":"Élizabeth Beaulieu","orcid":"0000-0001-8447-7073","position":3,"is_corresponding":false},{"id":1112101,"name":"Yeny B Arones","orcid":null,"position":4,"is_corresponding":false},{"id":1112102,"name":"Dana Gershenoff","orcid":null,"position":5,"is_corresponding":false},{"id":1112103,"name":"Kristie Hinton","orcid":null,"position":6,"is_corresponding":false},{"id":612100,"name":"Natalie Klein","orcid":"0000-0002-7532-4013","position":7,"is_corresponding":false},{"id":1112104,"name":"Jeanne Munezerou Uwizeye","orcid":null,"position":8,"is_corresponding":false},{"id":1112105,"name":"Eru Napia","orcid":null,"position":9,"is_corresponding":false},{"id":1111661,"name":"Carmen Viana Ramos","orcid":"0000-0003-3378-0149","position":10,"is_corresponding":false},{"id":1112106,"name":"O Fahina Tavake-Pasi","orcid":null,"position":11,"is_corresponding":false},{"id":930299,"name":"Jeannette Villalta","orcid":null,"position":12,"is_corresponding":false},{"id":1112107,"name":"Cathy Wolfsfeld","orcid":null,"position":13,"is_corresponding":false},{"id":742581,"name":"Brieanne Witte","orcid":null,"position":14,"is_corresponding":false},{"id":1112108,"name":"Ellen Maxfield","orcid":null,"position":15,"is_corresponding":false},{"id":290910,"name":"Kalani L. Raphael","orcid":"0000-0002-1378-2609","position":16,"is_corresponding":false},{"id":436979,"name":"Debra L. Simmons","orcid":null,"position":17,"is_corresponding":false},{"id":830253,"name":"Lauren Clark","orcid":"0000-0001-7668-2149","position":18,"is_corresponding":false},{"id":593054,"name":"Tamara Goldman Sher","orcid":null,"position":19,"is_corresponding":false},{"id":971112,"name":"Timothy W. Smith","orcid":"0000-0002-7307-855X","position":20,"is_corresponding":false},{"id":382634,"name":"Katherine J. W. Baucom","orcid":"0000-0002-0011-2526","position":21,"is_corresponding":false},{"id":760079,"name":"Madelyn Whitaker","orcid":"0000-0002-6532-1898","position":0,"is_corresponding":true}],"reference_count":72,"raw_metadata":null,"created_at":"2026-07-19T01:14:01.896928Z","pmid":"36797025","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}